BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 30745424)

  • 1. Natural history of renal tumours in von Hippel-Lindau disease: a large retrospective study of Chinese patients.
    Peng X; Chen J; Wang J; Peng S; Liu S; Ma K; Zhou J; Hong B; Zhou B; Zhang J; Cai L; Gong K
    J Med Genet; 2019 Jun; 56(6):380-387. PubMed ID: 30745424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical, surgical, pathological and follow-up features of kidney cancer patients with Von Hippel-Lindau syndrome: novel insights from a large consortium.
    Capitanio U; Rosiello G; Erdem S; Rowe I; Kara O; Roussel E; Campi R; Klatte T; Kriegmair MC; Sibona M; Bertolo R; Ouzaid I; Mir MC; Marra G; Larcher A; Montorsi F; Salonia A;
    World J Urol; 2021 Aug; 39(8):2969-2975. PubMed ID: 33416974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history of Von Hippel-Lindau disease-associated and sporadic clear cell renal cell carcinoma: a comparative study.
    Wang J; Zhang L; Qiu J; Li Z; Wu Y; Zhang C; Yao L; Gong K; Li X; Zhou L
    J Cancer Res Clin Oncol; 2022 Oct; 148(10):2631-2641. PubMed ID: 34709473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth kinetics in von Hippel-Lindau-associated renal cell carcinoma.
    Jilg CA; Neumann HP; Gläsker S; Schäfer O; Ardelt PU; Schwardt M; Schultze-Seemann W
    Urol Int; 2012; 88(1):71-8. PubMed ID: 22156657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation and Management of Apparently Sporadic Central Nervous System Haemangioblastoma for Evidence of Von Hippel-Lindau Disease.
    Furness H; Salfity L; Devereux J; Halliday D; Hanson H; Ruddy DM; Uk Vhl Study Group ; Shah N; Sultana G; Woodward ER; Sandford RN; Snape KM; Maher ER
    Genes (Basel); 2021 Sep; 12(9):. PubMed ID: 34573396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and molecular characterization of Brazilian families with von Hippel-Lindau disease: a need for delineating genotype-phenotype correlation.
    Gomy I; Molfetta GA; de Andrade Barreto E; Ferreira CA; Zanette DL; Casali-da-Rocha JC; Silva WA
    Fam Cancer; 2010 Dec; 9(4):635-42. PubMed ID: 20567917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.
    Clifford SC; Prowse AH; Affara NA; Buys CH; Maher ER
    Genes Chromosomes Cancer; 1998 Jul; 22(3):200-9. PubMed ID: 9624531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel missense mutation (N78D) in a family with von Hippel-Lindau disease with central nervous system haemangioblastomas, pancreatic and renal cysts.
    Cingoz S; van der Luijt RB; Kurt E; Apaydin M; Akkol I; Ozgen MH
    Fam Cancer; 2013 Mar; 12(1):111-7. PubMed ID: 23224817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of molecular genetic analysis of the VHL gene in patients with haemangioblastomas of the central nervous system.
    Gläsker S; Bender BU; Apel TW; Natt E; van Velthoven V; Scheremet R; Zentner J; Neumann HP
    J Neurol Neurosurg Psychiatry; 1999 Dec; 67(6):758-62. PubMed ID: 10567493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for survival in patients with von Hippel-Lindau disease.
    Wang JY; Peng SH; Li T; Ning XH; Liu SJ; Hong BA; Liu JY; Wu PJ; Zhou BW; Zhou JC; Qi NN; Peng X; Zhang JF; Ma KF; Cai L; Gong K
    J Med Genet; 2018 May; 55(5):322-328. PubMed ID: 29330336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A germline 1;3 translocation disrupting the
    Ricketts CJ; Vocke CD; Lang M; Chen X; Zhao Y; Tran B; Tandon M; Schmidt LS; Ball MW; Linehan WM
    J Med Genet; 2022 Jan; 59(1):18-22. PubMed ID: 33067352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline mutations in the new E1' cryptic exon of the
    Buffet A; Calsina B; Flores S; Giraud S; Lenglet M; Romanet P; Deflorenne E; Aller J; Bourdeau I; Bressac-de Paillerets B; Calatayud M; Dehais C; De Mones Del Pujol E; Elenkova A; Herman P; Kamenický P; Lejeune S; Sadoul JL; Barlier A; Richard S; Favier J; Burnichon N; Gardie B; Dahia PL; Robledo M; Gimenez-Roqueplo AP
    J Med Genet; 2020 Nov; 57(11):752-759. PubMed ID: 31996412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotype-phenotype correlations and clinical outcomes of patients with von Hippel-Lindau disease with large deletions.
    Zhang K; Yang W; Ma K; Qiu J; Li L; Xu Y; Zhang Z; Yu C; Zhou J; Gong Y; Cai L; Gong K
    J Med Genet; 2023 May; 60(5):477-483. PubMed ID: 37080588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Family history of von Hippel-Lindau disease was uncommon in Chinese patients: suggesting the higher frequency of de novo mutations in VHL gene in these patients.
    Wu P; Zhang N; Wang X; Ning X; Li T; Bu D; Gong K
    J Hum Genet; 2012 Apr; 57(4):238-43. PubMed ID: 22357542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic study of a large Chinese kindred with von Hippel-Lindau disease.
    Huang YR; Zhang J; Wang JD; Fan XD
    Chin Med J (Engl); 2004 Apr; 117(4):552-7. PubMed ID: 15109448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel and recurrent germline mutations in the VHL gene in 5 Arab patients with Von Hippel-Lindau disease.
    Faiyaz-Ul-Haque M; Jamil M; Aslam M; Abalkhail H; Al-Dayel F; Basit S; Nawaz Z; Zaidi SHE
    Cancer Genet; 2020 May; 243():1-6. PubMed ID: 32179488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotype-phenotype correlations in Chinese von Hippel-Lindau disease patients.
    Peng S; Shepard MJ; Wang J; Li T; Ning X; Cai L; Zhuang Z; Gong K
    Oncotarget; 2017 Jun; 8(24):38456-38465. PubMed ID: 28388566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three novel germ-line VHL mutations in Hungarian von Hippel-Lindau patients, including a nonsense mutation in a fifteen-year-old boy with renal cell carcinoma.
    Losonczy G; Fazakas F; Pfliegler G; Komáromi I; Balázs E; Pénzes K; Berta A
    BMC Med Genet; 2013 Jan; 14():3. PubMed ID: 23298237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal tumor size is an independent prognostic factor for overall survival in von Hippel-Lindau disease.
    Kwon T; Jeong IG; Pak S; You D; Song C; Hong JH; Ahn H; Kim CS
    J Cancer Res Clin Oncol; 2014 Jul; 140(7):1171-7. PubMed ID: 24671227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. von Hippel-Lindau mutants in renal cell carcinoma are regulated by increased expression of RSUME.
    Tedesco L; Elguero B; Pacin DG; Senin S; Pollak C; Garcia Marchiñena PA; Jurado AM; Isola M; Labanca MJ; Palazzo M; Yankilevich P; Fuertes M; Arzt E
    Cell Death Dis; 2019 Mar; 10(4):266. PubMed ID: 30890701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.